Learn more

INST ONEWORLD HEALTH

Overview
  • Total Patents
    38
About

INST ONEWORLD HEALTH has a total of 38 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are C4X DISCOVERY LTD, FUJIMOTO BROTHERS CO LTD and FYFE MATTHEW COLIN THOR.

Patent filings per year

Chart showing INST ONEWORLD HEALTHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Doyle Kevin James 23
#2 Russell Michael Geoffrey Neil 12
#3 Jones Graham Peter 8
#4 Peach Joanne 8
#5 Macritchie Jacqueline Anne 7
#6 Nguyen Tue H 6
#7 De Hostos Eugenio L 4
#8 De Hostos Eugenio 4
#9 Brown David 4
#10 Vater Huw David 4

Latest patents

Publication Filing date Title
WO2013019731A2 Phosphate prodrugs
WO2013019169A1 Phosphate prodrugs
WO2011133596A1 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
WO2011133600A1 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
US2010267725A1 Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
US2010267706A1 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
EP2421528A1 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
WO2010123822A1 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
US2010267741A1 Compounds, compositions and methods comprising pyrazole derivatives
US2010144733A1 Compounds, compositions and methods comprising heteroaromatic derivatives
US2011237528A1 Compositions and methods comprising imidazole and triazole derivatives
US2009318429A1 Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
US2009263853A1 High-Throughput Cell-Based CFTR Assay
WO2009131957A2 Compounds, compositions and methods comprising oxadiazole derivatives
US2010099677A1 Compounds, Compositions and Methods Comprising Thiazole Derivatives
US2009264433A1 Compounds, Compositions and Methods Comprising Triazine Derivatives
US2009270398A1 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
US2009264481A1 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
US2009264471A1 Compounds, Compositions and Methods Comprising Triazole Derivatives
CN101668732A CFTR inhibitor compound and uses thereof